Polyuria and polydipsia in a young child: Diagnostic considerations and identification of novel mutation causing familial neurohypophyseal diabetes insipidus

Pituitary

Volumn 15, Issue , 2012, Pages S1-S5

  Stephen, Matthew D ^a   Fenwick, Raymond G ^b   Brosnan, Patrick G ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Antidiuretic hormone; Arginine vasopressin; Central; Diabetes insipidus; Familial; Neurohypophyseal; Polydipsia; Polyuria

Indexed keywords

ARGIPRESSIN; DESMOPRESSIN; GUANINE; DESMOPRESSIN ACETATE; GLUTAMIC ACID; GLYCINE;

AMPLICON; ARTICLE; AVP GENE; CASE REPORT; CAUCASIAN; CHILD; CLINICAL ARTICLE; DIABETES INSIPIDUS; DISEASE EXACERBATION; DISEASE SEVERITY; DNA SEQUENCE; FAMILIAL DISEASE; FAMILIAL NEUROHYPOPHYSEAL DIABETES INSIPIDUS; FAMILY HISTORY; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; KIDNEY CONCENTRATING CAPACITY; MALE; NEUROHYPOPHYSIS DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYDIPSIA; POLYMERASE CHAIN REACTION; POLYURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SERUM OSMOLALITY; URINE OSMOLALITY; WATER DEPRIVATION; GENETICS; MUTATION; NEUROGENIC DIABETES INSIPIDUS; AMINO ACID SUBSTITUTION; BODY BUILD; BODY WEIGHT; CHILD DEVELOPMENT; CLINICAL FEATURE; DNA ISOLATION; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC RISK; INHERITANCE; MEDICAL HISTORY; NUCLEOTIDE SEQUENCE; PHYSICAL EXAMINATION; RISK ASSESSMENT;

CHILD, PRESCHOOL; DIABETES INSIPIDUS, NEUROGENIC; HUMANS; MALE; MUTATION; POLYDIPSIA; POLYURIA;

EID: 77950841083     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-010-0230-y     Document Type: Article

References (26)

1. Fluck CE, Deladoey J, Nayak S, Zeller O, Kopp P, Mullis PE (2001) Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II). Eur J Endocrinol 145(4):439-444
2. Polymeropoulos MH, Swift RG, Swift M (1994) Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nat Genet 8(1):95-97
3. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, BernalMizrachi E et al (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20(2):143-148
4. Rao VV, Loffler C, Battey J, Hansmann I (1992) The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenet Cell Genet 61(4):271-273
5. Repaske DR, Phillips JA 3rd, Kirby LT, Tze WJ, D’Ercole AJ, Battey J (1990) Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 70(3):752-757
6. Sausville E, Carney D, Battey J (1985) The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem 260(18):10236-10241
7. Crumley J, Bichet D, Morgan K, Arthus MF, Binette D, Lema J, Lonergan M, Michaud A, Turner M, Tzenova J, Yan R. Nephrogenic and neurogenic diabetes insipidus
8. Willcutts MD, Felner E, White PC (1999) Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Human Mol Genet 8(7):1303-1307
9. Land H, Grez M, Ruppert S, Schmale H, Rehbein M, Richter D et al (1983) Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature 302(5906):342-344
10. Land H, Schutz G, Schmale H, Richter D (1982) Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressinneurophysin II precursor. Nature 295(5847):299-303
11. Brownstein MJ, Russell JT, Gainer H (1980) Synthesis, transport, and release of posterior pituitary hormones. Science 207(4429): 373-378
12. Fassina G, Chaiken IM (1988) Structural requirements of peptide hormone binding for peptide-potentiated self-association of bovine neurophysin II. J Biol Chem 263(27):13539-13543
13. Rholam M, Nicolas P, Cohen P (1982) Binding of neurohypophyseal peptides to neurophysin dimer promotes formation of compact and spherical complexes. Biochemistry 21(20):4968-4973
14. Russell TA, Ito M, Yu RN, Martinson FA, Weiss J, Jameson JL (2003) A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressinproducing neurons. J Clin Invest 112(11):1697-1706
15. Ito M, Yu RN, Jameson JL (1999) Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J Biol Chem 274(13):9029-9037
16. Ito M, Jameson JL (1997) Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J Clin Invest 99(8):1897-1905
17. Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregersen N, Bolund L et al (2004) Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 89(9):4521-4531
18. Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregersen N, Bolund L et al (2004) Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf) 60(1):125-136
19. Siggaard C, Rittig S, Corydon TJ, Andreasen PH, Jensen TG, Andresen BS et al (1999) Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. J Clin Endocrinol Metab 84(8):2933-2941
20. Elias PC, Elias LL, Torres N, Moreira AC, Antunes-Rodrigues J, Castro M (2003) Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clin Endocrinol (Oxf) 59(4):511-518
21. Sunyaev S. Polyphen: prediction of functional effects of nsSNPs
22. Heppner C, Kotzka J, Bullmann C, Krone W, Muller-Wieland D (1998) Identification of mutations of the arginine vasopressinneurophysin II gene in two kindreds with familial central diabetes insipidus. J Clin Endocrinol Metab 83(2):693-696
23. Gagliardi PC, Bernasconi S, Repaske DR (1997) Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23 -[Val in neurophysin II. J Clin Endocrinol Metab 82(11):3643-3646
24. Chitturi S, Harris M, Thomsett MJ, Bowling F, McGown I, Cowley D et al (2008) Utility of AVP gene testing in familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf) 69(6):926-930
25. Leger J, Velasquez A, Garel C, Hassan M, Czernichow P (1999) Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metab 84(6):1954-1960
26. Ramelli GP, von der Weid N, Stanga Z, Mullis PE, Buergi U (1998) Suprasellar germinomas in childhood and adolescence: diagnostic pitfalls. J Pediatr Endocrinol Metab 11(6):693-697